13 hours Morgan Stanley upgrades Vir Biotechnology to ‘overweight,’ raises PT to $20 Investing.com
Morgan Stanley upgrades Vir Biotechnology to ‘overweight,’ raises PT to $20.
XMorgan Stanley upgrades Vir Biotechnology to ‘overweight,’ raises PT to $20.
X